{"transactions":[{"id":1098097,"issuer":{"id":7276,"kind":"organization","name":"Tevogen Inc.","symbol":"TVGN"},"owners":[{"id":77877,"kind":"person","name":"Khan Sadiq","position":1,"cik":"0002011764","reported_name":"Khan Sadiq","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-07-01T16:49:18.000Z","date":"2025-06-27","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan, which will vest ratably in three equal annual installments commencing on June 27, 2030, provided that the reporting person remains in service with the Issuer at such dates."}],"balance_after":1169618,"source":{"system":"sec-edgar","filing":"0001062993-25-012331","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011764/000106299325012331/form4.xml","form_type":"4"}},{"id":1638698,"issuer":{"id":7276,"kind":"organization","name":"Tevogen Inc.","symbol":"TVGN"},"owners":[{"id":77877,"kind":"person","name":"Khan Sadiq","position":1,"cik":"0002011764","reported_name":"Khan Sadiq","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-02-16T17:24:32.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":969618,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 14, 2024, pursuant to that certain Agreement and Plan of Merger, dated as of June 28, 2023, by and among the Issuer, Semper Merger Sub, Inc., and Tevogen Bio Inc (\"Tevogen\"), each issued and outstanding share of common stock of Tevogen was automatically cancelled and converted into approximately 4.8481 shares of the common stock of the Issuer."}],"balance_after":969618,"source":{"system":"sec-edgar","filing":"0001062993-24-003489","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2011764/000106299324003489/form4.xml","form_type":"4"}}]}